2026-09-21 — Arm jumps 17% in a Meta-driven CPU rally, up about 32% in three sessions

• Arm Holdings rose 17.16% on Monday 09-21 to close at $322.90, up about 32% in three sessions from $243.98 on 09-16, as Meta’s new Muse AI agent, which topped Apple’s US App Store, revived the trade in the central processors that coordinate agentic workloads. Meta is the lead partner and co-developer of Arm’s in-house “AGI CPU”, the first chip Arm has sold itself rather than licensed, so the rally lands directly on this thread’s question of whether Arm can convert leverage into its own silicon revenue; Intel rose about 12% and AMD closed above $1 trillion the same session. Arm’s move follows CEO Rene Haas’s 09-16 statement that AGI-CPU demand is “off the charts”. (Bloomberg, FinanceFeeds)

2026-09-18 — SoftBank raises the loan secured on its Arm shares to $25 billion instead of selling them

• SoftBank increased its margin loan backed by Arm Holdings shares by $5 billion to $25 billion, renegotiating with creditors this month, rather than selling any of its roughly 87% stake. Bloomberg reported it on 09-18 alongside SoftBank’s wider AI-funding push. It is the live follow-through on this thread’s watch that SoftBank treats Arm as loan collateral, not a sell-down: the earlier $20 billion facility (which faced a December 2025 deadline with its outcome unresolved on this thread) has been upsized rather than unwound, so the parent’s funding of its AI bets still rests on Arm’s share price, which had fallen about 45% from its June peak by mid-September. (Bloomberg, Investing.com)

2026-09-16 — CEO tells CNBC demand is “off the charts,” rebuilds confidence in the $2B AGI-CPU target; stock jumps ~7%

• Arm CEO Rene Haas told CNBC’s Jim Cramer (09-16) that his confidence in hitting the $2 billion AGI-CPU demand target — flagged in May, cut to $1B on foundry-capacity worries, then partially rebuilt by July — is now higher than at the July earnings call, and that “data center is going to be our largest business.” He described the constraint as manufacturing capacity (“wafers, substrates, testers, and memory”), not demand, which he called “off the charts.” Shares rose roughly 7% on the comments (still ~45% below June’s peak) — a direct hit on this thread’s central question of whether Arm converts leverage into economics. Corroborated across CNBC, 24/7 Wall St., Invezz, and TradingKey. (CNBC, 24/7 Wall St.)
• New supporting numbers: data-center royalties more than doubled y/y last quarter, and Arm shipped 500 million Neoverse cores in nine months versus six years for the first billion — plus a first look at the AGI-CPU’s margin profile, launching in the high-30s/low-40s% gross-margin range (below traditional IP licensing) with management targeting ~50% over subsequent years. (24/7 Wall St.)

2026-08-24 — IBM builds native Arm support into its next mainframe chip; Arm shares jump on the tie-up plus a reported $2B AI-chip backlog

• IBM unveiled its next-generation dual-architecture mainframe processor — the first chip to run IBM Z and Arm-native workloads on the same cores — under a strategic collaboration first announced 2026-04-02 and now shipping as real silicon, aimed at running Arm-native AI applications on Z mainframes and LinuxONE servers. Confirmed via both companies’ own newsrooms and corroborated by VentureBeat, Forbes, and SiliconANGLE. This is a genuinely new kind of design win for Arm’s royalty base — enterprise mainframes, not the mobile/cloud/AI-accelerator markets the thread has tracked so far. (IBM Newsroom, Arm Newsroom, VentureBeat)
• Arm shares jumped after hours on the IBM news plus a separately reported $2B AI-chip order backlog it “cannot fill yet” — the first concrete evidence since the thread opened that Arm’s non-royalty chip ambitions (the in-house “AGI CPU”) are converting into an actual order book, not just an announced pivot. Stock context: Arm had been down as much as 46% from its June peak before this. (finance.biggo.com, TradingKey)

2026-07-31 — A one-day snapback: Arm +9% on the broad Tokyo chip rally

• Arm rose 9% overnight as part of a broad Tokyo AI/semiconductor rally (Nikkei 225 +4.37%) triggered by strong US tech earnings — reversing, at least for one session, the guidance-cut selloff that closed out 07-29’s beat-and-raise coverage. See Son All-In for the fuller Tokyo-session read (SoftBank itself hit limit-up the same day, still ahead of its own 08-06 earnings). (Bloomberg Japan)

2026-07-29 — A clean beat-and-raise, and the stock fell anyway

• Q1 FY2027: revenue $1.289B (+22%), royalty $715M (a Q1 record), licensing $574M (a Q1 record), non-GAAP EPS $0.45 — all above consensus, with Q2 guidance ($1.38B / $0.47) also above estimates. (Arm Newsroom)
• AGI-CPU demand now exceeds $2B across FY27-FY28, double the initial forecast, with capacity already sold out and data-center royalty revenue more than doubling year-over-year — the AI-specific story genuinely strengthened. (Arm Newsroom)
• What actually moved the stock: full-year royalty growth guidance was cut to “high teens” from roughly 20%, on expected double-digit smartphone-market weakness. The stock fell further after-hours (-7 to -8%) and stayed down premarket (-4.95%), extending the pre-earnings -28% run rather than reversing it. (MarketScreener)
• This is the sharpest rotation-away-from-chips signal of the four prints tonight — a genuinely good AI-specific number was not enough to buy relief once a legacy-business guidance cut sat next to it.

← Backstory (crawl 2026-07-28 → artifacts/findings/arm-royalty-regime-2026-07-28.md)

• Qualcomm wins the trial, Arm appeals — a Delaware judge rejected Arm’s last remaining claim in the Qualcomm licensing dispute (the architecture-license question the Dec-2024 jury deadlocked on), handing Qualcomm a full trial-court win; Arm said it would appeal. 2026 appeal status not found. (The Register)
• Royalty growth stayed real — four straight >$1B quarters through FY2026 (Jul-25 → May-26), Armv9 + CSS cited as the driver, royalty revenue +25% YoY in Q1 FY26; exact FY2026 full-year digits ($4.92B rev / $2.61B royalty) not independently re-verified this session — IR pages returned 404. No v10 architecture found. (Arm Newsroom)
• SoftBank leans on Arm shares as collateral, not a sell-down — sought a $5B loan against Arm shares (Oct-25) and a separate $20B Arm-collateral margin loan facing a Dec-2025 deadline (outcome unresolved), while also renewing (Jul-26) a $10B loan against its OpenAI stake — the same crown-jewel-leverage playbook, two different collateral pools. (Reuters)
• Raspberry Pi flag likely resolved, not confirmed — an Arm subsidiary invested £50M into a £60M Raspberry Pi share placing (Apr-23-26), a follow-on top-up of a stake held since 2023 — timing fits the FY26 20-F’s unresolved subsequent-event flag but this crawl could not directly confirm the link. (businesscloud.co.uk)
• Arm shipped its first-ever in-house chip — the “Arm AGI CPU” (136-core, Neoverse-based, AI-inference-targeted) launched 2026-03-24, Arm’s first self-designed chip in 35 years; Meta is the launch customer, with OpenAI/Cerebras/Cloudflare also named. Arm now competes with some of its own licensees. (TechCrunch)
• Datacenter share grew fast, size disputed — server-CPU revenue share roughly doubled 15%→25% YoY by Sep-25 (short of Arm’s own 50%-by-end-2025 target); by mid-2026 competing figures (a non-Arm- specific 47.9% “non-x86” IDC number, and an unnamed Arm exec’s >50% hyperclaim to Nikkei) don’t reconcile to one clean number. Meta signed for both AWS Graviton5 and standalone Nvidia Grace CPUs. (The Register)
• RISC-V went from theory to funded threat — Qualcomm acquired RISC-V design firm Ventana Micro Systems (Dec-25), explicitly framed as hedging Arm dependence amid the litigation, and by mid-2026 was reportedly in talks to acquire RISC-V AI-chip startup Tenstorrent for $8-10B; China (Alibaba’s XuanTie C950, SpacemiT) pushed its own RISC-V self-sufficiency line in parallel. (Qualcomm)
• Stock turned volatile into July — ARM fell 17.4% (Jul-18, tied to AI-chip pullback + China export concerns) and was down 28% over the month heading into 2026-07-29 Q1 FY2027 earnings — the next real test of whether the royalty + AGI-CPU story shows up in guidance. (24/7 Wall St.)